363 related articles for article (PubMed ID: 24605040)
1. Addition of prokinetics to PPI therapy in gastroesophageal reflux disease: a meta-analysis.
Ren LH; Chen WX; Qian LJ; Li S; Gu M; Shi RH
World J Gastroenterol; 2014 Mar; 20(9):2412-9. PubMed ID: 24605040
[TBL] [Abstract][Full Text] [Related]
2. The treatment efficacy of adding prokinetics to PPIs for gastroesophageal reflux disease: a meta-analysis.
Xi L; Zhu J; Zhang H; Muktiali M; Li Y; Wu A
Esophagus; 2021 Jan; 18(1):144-151. PubMed ID: 32519226
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of the addition of prokinetics for proton pump inhibitor (PPI) resistant non-erosive reflux disease (NERD) patients: significance of frequency scale for the symptom of GERD (FSSG) on decision of treatment strategy.
Miyamoto M; Manabe N; Haruma K
Intern Med; 2010; 49(15):1469-76. PubMed ID: 20686276
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled trial comparing the efficacy of mosapride plus omeprazole combination therapy to omeprazole monotherapy in gastroesophageal reflux disease.
Yamaji Y; Isomura Y; Yoshida S; Yamada A; Hirata Y; Koike K
J Dig Dis; 2014 Sep; 15(9):469-76. PubMed ID: 24957863
[TBL] [Abstract][Full Text] [Related]
5. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2006 Jul; (3):CD002095. PubMed ID: 16855986
[TBL] [Abstract][Full Text] [Related]
6. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Sigterman KE; Bonis P; Lau J; Numans ME
Cochrane Database Syst Rev; 2010 Nov; (11):CD002095. PubMed ID: 21069670
[TBL] [Abstract][Full Text] [Related]
7. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
Sigterman KE; van Pinxteren B; Bonis PA; Lau J; Numans ME
Cochrane Database Syst Rev; 2013 May; 2013(5):CD002095. PubMed ID: 23728637
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Vonoprazan for Gastroesophageal Reflux Symptoms in Patients with Proton Pump Inhibitor-resistant Non-erosive Reflux Disease.
Niikura R; Yamada A; Hirata Y; Hayakawa Y; Takahashi A; Shinozaki T; Takeuchi Y; Fujishiro M; Koike K
Intern Med; 2018 Sep; 57(17):2443-2450. PubMed ID: 29607951
[TBL] [Abstract][Full Text] [Related]
9. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2004 Oct; (4):CD002095. PubMed ID: 15495027
[TBL] [Abstract][Full Text] [Related]
10. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2001; (4):CD002095. PubMed ID: 11687139
[TBL] [Abstract][Full Text] [Related]
11. A systematic review and meta-analysis of the efficacy of vonoprazan for proton pump inhibitor-resistant gastroesophageal reflux disease.
Simadibrata DM; Lesmana E; Fass R
J Gastroenterol Hepatol; 2024 May; 39(5):796-805. PubMed ID: 38263507
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitor for non-erosive reflux disease: a meta-analysis.
Zhang JX; Ji MY; Song J; Lei HB; Qiu S; Wang J; Ai MH; Wang J; Lv XG; Yang ZR; Dong WG
World J Gastroenterol; 2013 Dec; 19(45):8408-19. PubMed ID: 24363534
[TBL] [Abstract][Full Text] [Related]
14. Alginate therapy is effective treatment for gastroesophageal reflux disease symptoms: a systematic review and meta-analysis.
Leiman DA; Riff BP; Morgan S; Metz DC; Falk GW; French B; Umscheid CA; Lewis JD
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27671545
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Laparoscopic Nissen Fundoplication vs Transoral Incisionless Fundoplication or Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-analysis.
Richter JE; Kumar A; Lipka S; Miladinovic B; Velanovich V
Gastroenterology; 2018 Apr; 154(5):1298-1308.e7. PubMed ID: 29305934
[TBL] [Abstract][Full Text] [Related]
16. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2000; (2):CD002095. PubMed ID: 10796857
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of mosapride plus proton pump inhibitors for treatment of gastroesophageal reflux disease: a systematic review.
Liu Q; Feng CC; Wang EM; Yan XJ; Chen SL
World J Gastroenterol; 2013 Dec; 19(47):9111-8. PubMed ID: 24379638
[TBL] [Abstract][Full Text] [Related]
18. Frequency scale for symptoms of gastroesophageal reflux disease predicts the need for addition of prokinetics to proton pump inhibitor therapy.
Miyamoto M; Haruma K; Takeuchi K; Kuwabara M
J Gastroenterol Hepatol; 2008 May; 23(5):746-51. PubMed ID: 18028348
[TBL] [Abstract][Full Text] [Related]
19. Effect of on-demand vs continuous prescription of proton pump inhibitors on symptom burden and quality of life: results of a real-world randomized controlled trial in primary care patients with gastroesophageal reflux disease.
Andreasson A; Agréus L; Mastellos N; Bliźniuk G; Waśko-Czopnik D; Angelaki A; Theodosaki E; Lionis C; Hek K; Verheij R; Wright E; Durbaba S; Muris J; Bródka P; Saganowski S; Ethiér JF; Curcin V; Delaney B
Ann Med; 2024 Dec; 56(1):2354683. PubMed ID: 38753973
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
